Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The role of dendritic cells in cancer and anti-tumor immunity123
Emerging concepts in PD-1 checkpoint biology101
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease87
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity82
T cell immunity to SARS-CoV-260
Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair59
The role of neutrophil extracellular traps in cancer progression and metastasis58
Nanobodies in cancer57
G-CSF – A double edge sword in neutrophil mediated immunity50
Non-coding RNA-based regulation of inflammation50
Immunological approaches to HIV cure45
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion40
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs37
HIV vaccinology: 2021 update37
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic36
HIV replication and latency in monocytes and macrophages36
Radiotherapy: An immune response modifier for immuno-oncology36
Immune response after central nervous system injury35
Pyroptosis-induced inflammation and tissue damage35
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies35
G-CSF, the guardian of granulopoiesis35
The neglected brothers come of age: B cells and cancer33
A major mechanism for immunomodulation: Dietary fibres and acid metabolites32
The dual role of neutrophils in cancer32
Targeting GM-CSF in inflammatory and autoimmune disorders31
Broadly neutralizing antibodies for HIV-1 prevention and therapy31
Unexpected connections of the IL-23/IL-17 and IL-4/IL-13 cytokine axes in inflammatory arthritis and enthesitis29
The impact of immunopeptidomics: From basic research to clinical implementation29
Macrophage regulation & function in helminth infection29
GM-CSF: Master regulator of the T cell-phagocyte interface during inflammation29
Adaptive NK cell response to human cytomegalovirus: Facts and open issues27
Complement component C3: A structural perspective and potential therapeutic implications27
IL-3 in the development and function of basophils27
Colony stimulating factors in the nervous system26
IL-33: A central cytokine in helminth infections26
Residual immune dysfunction under antiretroviral therapy26
Immunomodulatory effects of G-CSF in cancer: Therapeutic implications26
Tumor resident regulatory T cells24
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet24
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?24
Targeting dendritic cells to advance cross-presentation and vaccination outcomes23
Pathways of MHC I cross-presentation of exogenous antigens23
Specialized pro-resolving mediators as modulators of immune responses23
Dimensions of neutrophil life and fate22
Immunity to fungi in the lung21
Therapeutic exploitation of neutrophils to fight cancer20
Clinical evaluation of colony-stimulating factor 1 receptor inhibitors20
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics19
Innovations in lymph node targeting nanocarriers19
Neutrophil metabolism in the cancer context19
Versatile neutrophil functions in cancer18
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer18
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel17
Complement activation in cancer: Effects on tumor-associated myeloid cells and immunosuppression17
Nanoparticles for generating antigen-specific T cells for immunotherapy17
Formyl peptide receptor 2 and heart disease16
Immune aging – A mechanism in autoimmune disease16
Basophils in antihelminth immunity15
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?15
The role of caspase-8 in inflammatory signalling and pyroptotic cell death15
Neglected no more: B cell-mediated anti-tumor immunity14
Shocking HIV-1 with immunomodulatory latency reversing agents14
Pyroptosis: A road to next-generation cancer immunotherapy14
Natural killer cells and type 1 innate lymphoid cells in cancer14
Pyroptosis in defense against intracellular bacteria14
The gut-brain vascular axis in neuroinflammation14
The evolving biology of cross-presentation13
Lessons in type 2 immunity: Neutrophils in Helminth infections13
The biogenesis of the immunopeptidome13
Nanoparticle theranostics in cardiovascular inflammation13
C3-targeted host-modulation approaches to oral inflammatory conditions13
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls13
What’s self got to do with it: Sources of heterogeneity among naive T cells13
IL-34, the rationale for its expression in physiological and pathological conditions13
Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women12
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging12
Nanoalum adjuvanted vaccines: small details make a big difference12
Microbiota-targeted therapies in inflammation resolution12
Impact of cancer cell-intrinsic features on neutrophil behavior12
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities12
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation12
The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions11
Redefining microglia states: Lessons and limits of human and mouse models to study microglia states in neurodegenerative diseases11
Checkpoint blockade toxicities: Insights into autoimmunity and treatment11
Antigen discovery for the development of cancer immunotherapy11
Cellular and molecular diversity in Rheumatoid Arthritis11
Pyroptosis and the cellular consequences of gasdermin pores11
Complexity of immune responses in COVID-1911
Contemplating immunopeptidomes to better predict them11
CD40-CD154: A perspective from type 2 immunity11
Mechanisms of climate change and related air pollution on the immune system leading to allergic disease and asthma11
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data11
Integrating immunopeptidome analysis for the design and development of cancer vaccines11
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)10
Multidimensional molecular controls defining NK/ILC1 identity in cancers10
Unconventional protein secretion by gasdermin pores10
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease10
Emerging features of MAIT cells and other unconventional T cell populations in human viral disease and vaccination.10
TREM2: A new player in the tumor microenvironment10
Polyvalent design in the cGAS-STING pathway10
Development of γδ T cells in the thymus – A human perspective10
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients10
The gut-enthesis axis and the pathogenesis of Spondyloarthritis10
Myeloid dysregulation and therapeutic intervention in COVID-199
Systems analysis of innate and adaptive immunity in Long COVID9
Western diet influences on microbiome and carcinogenesis9
DNGR-1-mediated cross-presentation of dead cell-associated antigens9
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC9
MHC-dressing on dendritic cells: Boosting anti-tumor immunity via unconventional tumor antigen presentation8
Microbial metabolites and immunotherapy: Basic rationale and clinical indications8
The gut mucus network: A dynamic liaison between microbes and the immune system8
Cross-presentation by the others8
Human thymus in health and disease: Recent advances in diagnosis and biology8
Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example8
Exploiting antifungal immunity in the clinical context8
Regulated cell death in neutrophils: From apoptosis to NETosis and pyroptosis8
Viral T-cell epitopes – Identification, characterization and clinical application8
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming8
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells8
“Under Pressure” – How fungi evade, exploit, and modulate cells of the innate immune system7
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives7
Immunity to pathogenic fungi in the eye7
Resolving inflammatory links between myocardial infarction and vascular dementia7
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond7
Pyroptosis in cardiovascular diseases: Pumping gasdermin on the fire7
Targeting the tissue-complosome for curbing inflammatory disease7
Mitochondria during T cell aging7
Natural killer cell responses to human oncogenic γ-herpesvirus infections7
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions7
Immunomodulatory and immunoregulatory nanomedicines for autoimmunity7
0.031727075576782